ABIM pitches self-paced MOC; RNA drug slices LDL cholesterol

Friday, September 6, 2019

ABIM: Self-paced MOC pathway under development
By Alicia Gallegos

The longitudinal assessment option will provide doctors with immediate feedback about answers and links to educational material.

Other stories:

1. siRNA drug safely halved LDL cholesterol in phase 3 ORION-11

The new drug inclisiran potently cut LDL cholesterol by inhibiting the PCSK9 enzyme.

2. Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality

In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.

3. Michigan becomes first state to ban flavored e-cigarettes

The state health agency is expected to issue rules outlining the ban within the next 30 days.

4. New report cites mental health challenges faced by separated immigrant children

Clinicians encounter significant difficulties when addressing needs of unaccompanied immigrant children in federal custody, OIG report finds.

You can contact the MDedge Daily Medical News by emailing us at [email protected] or following us on Twitter at @MDedgeTweets.